MMP2 and cancer: In particular, the PI MLN2238 reduces the invasion capability of two OS cell lines, reducing the expression of MMP2/9 proteins [41], and inducing cancer cells apoptosis, by activating Caspase-3, -8 and -9 in both OS [38] and other different tumors [42,43,44].